Accuracy of risk scores for patients with chronic hepatitis B receiving entecavir treatment.
Abstract
Background & Aims null Little is known about the validity of hepatocellular carcinoma (HCC) risk scores derived from treatment-naive patients with chronic hepatitis B for patients treated with entecavir. null Methods null We performed a retrospective-prospective cohort study of 1531 patients with chronic hepatitis B (age, 51 ± 12 years; 1099 male; 332 with clinical cirrhosis) who were treated with entecavir 0.5 mg daily for at least 12 months at...
Paper Details
Title
Accuracy of risk scores for patients with chronic hepatitis B receiving entecavir treatment.
Published Date
May 1, 2013
Journal
Volume
144
Issue
5
Pages
933 - 944
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History